| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |